We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

Back to rankings

165 hedge funds and large institutions have $340M invested in Sucampo Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 55 funds opening new positions, 54 increasing their positions, 43 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

588% more first-time investments, than exits

New positions opened: 55 | Existing positions closed: 8

48% more capital invested

Capital invested by funds: $229M → $340M (+$111M)

39% more funds holding

Funds holding: 119 → 165 (+46)

26% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 43

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

39% less call options, than puts

Call options by funds: $1.17M | Put options by funds: $1.91M

Holders
165
Holders Change
+46
Holders Change %
+38.66%
% of All Funds
4.13%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
55
Increased
54
Reduced
43
Closed
8
Calls
$1.17M
Puts
$1.91M
Net Calls
-$737K
Net Calls Change
-$936K

Top Buyers

Rank Fund Capital Flow
1
RI
Redwood Investments
Massachusetts
+$8.42M
2
UOC
UBS O'Connor
Illinois
+$6.98M
3
NI
Numeric Investors
Massachusetts
+$6.7M
4
Invesco
Invesco
Georgia
+$5.94M
5
LSV Asset Management
LSV Asset Management
Illinois
+$5.25M

Top Sellers

Rank Fund Capital Flow
1
Boston Partners
Boston Partners
Massachusetts
-$2.94M
2
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
-$1.69M
3
MCM
McKinley Capital Management
Alaska
-$1.44M
4
Prudential Financial
Prudential Financial
New Jersey
-$988K
5
MC
Menta Capital
California
-$842K
Name Holding Trade Value Shares
Change 		Change in
Stake
CCMH
26
Cornerstone Capital Management Holdings
New York
$3.56M +$1.48M +106,400 +68%
CEI
27
Clark Estates Inc
New York
$3.39M +$349K +25,000 +11%
EAM
28
EverPoint Asset Management
Connecticut
$2.91M +$209K +15,000 +8%
TCIM
29
TIAA CREF Investment Management
New York
$2.7M -$205K -14,690 -7%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$2.4M +$650K +46,565 +36%
Charles Schwab
31
Charles Schwab
California
$2.39M -$247K -17,690 -9%
AG
32
Algert Global
California
$2.35M +$2.42M +173,457 New
Goldman Sachs
33
Goldman Sachs
New York
$2.29M -$605K -43,372 -20%
Fidelity Investments
34
Fidelity Investments
Massachusetts
$2.24M -$188K -13,500 -8%
MC
35
Menta Capital
California
$2.24M -$842K -60,376 -27%
D.E. Shaw & Co
36
D.E. Shaw & Co
New York
$2.18M +$810K +58,058 +57%
DIA
37
Dana Investment Advisors
Wisconsin
$1.88M +$1.94M +138,721 New
Point72 Asset Management
38
Point72 Asset Management
Connecticut
$1.8M -$537K -38,500 -22%
MCM
39
McKinley Capital Management
Alaska
$1.75M -$1.44M -103,519 -44%
CS
40
Credit Suisse
Switzerland
$1.69M -$164K -11,747 -9%
CCM
41
Cadence Capital Management
Massachusetts
$1.58M +$408K +29,249 +33%
QI
42
QS Investors
New York
$1.57M -$316K -22,633 -16%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$1.55M +$1.11M +79,347 +227%
BA
44
BlackRock Advisors
Delaware
$1.51M -$331K -23,712 -18%
SB
45
Suntrust Banks
Georgia
$1.51M +$1.55M +111,431 New
ACM
46
Ativo Capital Management
Illinois
$1.48M +$237K +17,000 +18%
MCM
47
Matarin Capital Management
New York
$1.46M +$1.51M +108,092 New
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$1.33M +$482K +34,542 +55%
BIM
49
BlackRock Investment Management
Delaware
$1.25M -$5.65K -405 -0.4%
DCM
50
Dupont Capital Management
Delaware
$1.17M -$400K -28,676 -25%
1
2
3 4 5

SCMP Hedge Fund Activity: Q4 2016 in Review

165 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q4 2016, worth a combined $340M — up 48% from $229M a quarter earlier.

Buyers outnumbered sellers: 55 funds opened new SCMP positions and 8 closed out — a net gain of 47 holders — while 54 added to existing stakes and 43 trimmed.

The largest buyer was Redwood Investments, opening a new position worth an estimated $8.42M. The largest seller was Boston Partners, exiting entirely with an estimated $2.94M sold.

  • 165 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q4 2016, up from 119 in Q3 2016.
  • Funds reported $340M of Sucampo Pharmaceuticals, Inc. stock for Q4 2016, up 48% quarter-over-quarter.
  • 55 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q4 2016 and 8 closed out, a net change of +47 holders.
  • The largest Sucampo Pharmaceuticals, Inc. buyer in Q4 2016 was Redwood Investments, an estimated $8.42M added.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q4 2016 was Boston Partners, an estimated $2.94M sold.

Based on aggregated 13F filings for Q4 2016.